{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-12T12:23:20.885488+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQODBvYnVaZUlPd2FCMWdvTlN1bzk0YkhOdVdUeEdTN1pNOTN0N3hPbnhtazdMSk1zcWswbHRwZGZ5dTc1TGJLaVNVek9hMV9PTl82VkZTSEwzMklhblEyTUFYRXFsQUZhRDFCZ0RZdUx0NE5RaDRHNnREYTFQU2hxdTREMFYxVXB6dFZ1QzlncTJGSVU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQODBvYnVaZUlPd2FCMWdvTlN1bzk0YkhOdVdUeEdTN1pNOTN0N3hPbnhtazdMSk1zcWswbHRwZGZ5dTc1TGJLaVNVek9hMV9PTl82VkZTSEwzMklhblEyTUFYRXFsQUZhRDFCZ0RZdUx0NE5RaDRHNnREYTFQU2hxdTREMFYxVXB6dFZ1QzlncTJGSVU?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-12T10:50:42+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade) (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOaE56OUloZWVVc3dXc2h4bzdmdnFrOFV5MVUtRmZlSWs0amFNUTdmelJFdWNVZjlRdFNxUkFtSFZHekMySktjWTNnWTlBMjZKa3gxbTlRWVM3cHg1djFJcXFoclBVMnh2MGRfcGRUa2h5dDVyc01hUktWYW9QTmFMRTlWVms3SktER25ISi1DR0VKMzZfLXc2c1N4TDdRNkhNV0dKejVyMjJyaS02VVpUZnNUOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOaE56OUloZWVVc3dXc2h4bzdmdnFrOFV5MVUtRmZlSWs0amFNUTdmelJFdWNVZjlRdFNxUkFtSFZHekMySktjWTNnWTlBMjZKa3gxbTlRWVM3cHg1djFJcXFoclBVMnh2MGRfcGRUa2h5dDVyc01hUktWYW9QTmFMRTlWVms3SktER25ISi1DR0VKMzZfLXc2c1N4TDdRNkhNV0dKejVyMjJyaS02VVpUZnNUOA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade) (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-11T20:47:24+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharmaceuticals: A Biotech Powerhouse Poised for Rebound After Oversold Correction - AInvest",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNQkFhMlp4N0I5M0kzblBrdW8yclRZOWhIM1B6NDVTbGphQlpYYkhWOTJidElVMXdlTE1hNlVuRU5MdWlnSFZHVlRsOWxPUmZTWkhEd0dIczJwa3VoejNIcEdWeE1KRi1POUh3Wk5oMGVQdU1qNEhON2ZNalB3ejFCX0xJcXRlZ0p0X2dHTUdtS2NPUklzVTE0bjlVcklWUFA3Rm4yZXptRDhUTTNrRXhkUg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNQkFhMlp4N0I5M0kzblBrdW8yclRZOWhIM1B6NDVTbGphQlpYYkhWOTJidElVMXdlTE1hNlVuRU5MdWlnSFZHVlRsOWxPUmZTWkhEd0dIczJwa3VoejNIcEdWeE1KRi1POUh3Wk5oMGVQdU1qNEhON2ZNalB3ejFCX0xJcXRlZ0p0X2dHTUdtS2NPUklzVTE0bjlVcklWUFA3Rm4yZXptRDhUTTNrRXhkUg?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Biotech Powerhouse Poised for Rebound After Oversold Correction</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-11T21:01:58+00:00",
      "source": "AInvest"
    },
    {
      "title": "Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5\" target=\"_blank\">Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-05T20:20:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex's trial failure, scrapped study cloud pain drug push; shares slump - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5\" target=\"_blank\">Vertex's trial failure, scrapped study cloud pain drug push; shares slump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T23:38:51+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-08-11T13:09:30+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Vertex drops aspiring Journavx follower in acute pain after phase 2 failure - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQNE9GQlVQWG5kQnBnZlFPUS1oTklTTnBaREtpMWFxbDJaakt5bExadmVJLUREME5Lem4yRDdKLTV0Qlo1bUtycUZ1anV6emNPb25XaXRoSVJXRHZodXZVZzl1MmhHNkdUcE8tc2l3eGprcFN0Z3RLYVhDZGpBTURLNGZzUGFOeVlTZy1XQXY1TUdIakxmM0ZPQmMwMTE5LUxRVllKc1JVbGI0amNCODBr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxQNE9GQlVQWG5kQnBnZlFPUS1oTklTTnBaREtpMWFxbDJaakt5bExadmVJLUREME5Lem4yRDdKLTV0Qlo1bUtycUZ1anV6emNPb25XaXRoSVJXRHZodXZVZzl1MmhHNkdUcE8tc2l3eGprcFN0Z3RLYVhDZGpBTURLNGZzUGFOeVlTZy1XQXY1TUdIakxmM0ZPQmMwMTE5LUxRVllKc1JVbGI0amNCODBr?oc=5\" target=\"_blank\">Vertex drops aspiring Journavx follower in acute pain after phase 2 failure</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-08-04T21:34:36+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "The Escalator: Geron, Vertex Pharmaceuticals, Butler/Till and more - Medical Marketing and Media",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQMENsbFVVWWpEbGVLMXQwOXdvOGFxQnJQZ2poZW01ME56ZFdMVldIWEpjRllSTGw1NGxCUko1V3ZwbWlGTlNUVDBmNE5ON0hYeVhRSUlFd0t2X0pUMXRDMVJrSFNTV1BaRWNHZHVKanZPR1JzWGRJUU8tN1lVcENjNUpsNFd1NS1xRzNfb1hYUm1rVVplendwT3ZJc3I?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxQMENsbFVVWWpEbGVLMXQwOXdvOGFxQnJQZ2poZW01ME56ZFdMVldIWEpjRllSTGw1NGxCUko1V3ZwbWlGTlNUVDBmNE5ON0hYeVhRSUlFd0t2X0pUMXRDMVJrSFNTV1BaRWNHZHVKanZPR1JzWGRJUU8tN1lVcENjNUpsNFd1NS1xRzNfb1hYUm1rVVplendwT3ZJc3I?oc=5\" target=\"_blank\">The Escalator: Geron, Vertex Pharmaceuticals, Butler/Till and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Marketing and Media</font>",
      "published": "2025-08-06T20:07:09+00:00",
      "source": "Medical Marketing and Media"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Growth and Strategic Advances - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxORGtLZUtKRE5VMFp1WV9YQ3VFU2QySUg0c3pYQjIxNXFDTzlldmw3SGF5emctdmxCWVllTTgyUThPUU1xTkNDRUx2a1ZUTWxUUzg0VVMxd0YzVXJTelFPYk0xdDZHa0pobUJPcVRnenlldm05d2NoTzlPc21vamI5QTVaRTk5UVRDaGRpYm1BbjZPM1h3bWtrMkxueUg0azRQdmwzRi1UMHVsWldERzBQQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxORGtLZUtKRE5VMFp1WV9YQ3VFU2QySUg0c3pYQjIxNXFDTzlldmw3SGF5emctdmxCWVllTTgyUThPUU1xTkNDRUx2a1ZUTWxUUzg0VVMxd0YzVXJTelFPYk0xdDZHa0pobUJPcVRnenlldm05d2NoTzlPc21vamI5QTVaRTk5UVRDaGRpYm1BbjZPM1h3bWtrMkxueUg0azRQdmwzRi1UMHVsWldERzBQQw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth and Strategic Advances</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-06T00:26:42+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Pharmaceuticals' Q2 2025: Unpacking Contradictions in JOURNAVX Strategy, Trial Timelines, and Market Dynamics - AInvest",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcWNEMnctWDJfYzdsYVNWM0RvVFFfSFZieTFPa1Y2YmhJWnVUUmVVMjZ4V0U2bnpXLUtWd28yQVJiU0V2MS1kaldabjFIODFUNnpNcWZwRU9fRXVFUjZXYzhLNEtMZnFaVW10LXhDeGlPT2xQLVJUQmMxRi1ac3lPTlZGV3U3QWN2ZEg3NkRqZW5KcmJ2c2lIZ2NJQzQ1UlhoOFNMblFWbVFxdFVrZmNjNU9faGlxdFpxZDlZbkl3OWFoS0plM2FrajJ3Q25xVkRXLWg5Unpvbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcWNEMnctWDJfYzdsYVNWM0RvVFFfSFZieTFPa1Y2YmhJWnVUUmVVMjZ4V0U2bnpXLUtWd28yQVJiU0V2MS1kaldabjFIODFUNnpNcWZwRU9fRXVFUjZXYzhLNEtMZnFaVW10LXhDeGlPT2xQLVJUQmMxRi1ac3lPTlZGV3U3QWN2ZEg3NkRqZW5KcmJ2c2lIZ2NJQzQ1UlhoOFNMblFWbVFxdFVrZmNjNU9faGlxdFpxZDlZbkl3OWFoS0plM2FrajJ3Q25xVkRXLWg5Unpvbw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' Q2 2025: Unpacking Contradictions in JOURNAVX Strategy, Trial Timelines, and Market Dynamics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-05T01:37:26+00:00",
      "source": "AInvest"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-11",
      "close": 374.4599914550781
    },
    "history": [
      {
        "date": "2025-08-01",
        "close": 462.1300048828125
      },
      {
        "date": "2025-08-04",
        "close": 472.2699890136719
      },
      {
        "date": "2025-08-05",
        "close": 374.9800109863281
      },
      {
        "date": "2025-08-06",
        "close": 385.6499938964844
      },
      {
        "date": "2025-08-07",
        "close": 375.6300048828125
      },
      {
        "date": "2025-08-08",
        "close": 366.5400085449219
      },
      {
        "date": "2025-08-11",
        "close": 374.4599914550781
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}